Biocure Technology Inc.
CUREX
CNSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -2.99M | -3.06M | -1.10M | -1.31M | 1.21M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.89M | 2.96M | 936.50K | 962.90K | -1.86M |
| Change in Net Operating Assets | 142.60K | 153.00K | 181.70K | 187.40K | 319.50K |
| Cash from Operations | 52.30K | 49.30K | 21.00K | -160.80K | -328.70K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 0.00 | 14.80K | 32.10K | 57.90K |
| Cash from Investing | 0.00 | 0.00 | 14.80K | 32.10K | 57.90K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -47.00K | -47.00K | -47.00K | -47.00K | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -3.00K | -3.00K | -9.00K | 187.40K | 322.40K |
| Cash from Financing | -36.80K | -36.80K | -41.30K | 103.90K | 238.00K |
| Foreign Exchange rate Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 300.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | 300.00 |
| Net Change in Cash | 15.60K | 12.60K | -5.40K | -24.80K | -32.40K |